Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosinopril in High Cardiovascular Risk
NCT00051389Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 2002
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fosinopril in cardiovascular diseases (CVD), sponsored by National Heart, Lung, and Blood Institute. Started Feb 2002; status: completed.
02
Drugs
fosinopril
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT00051389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051389.